Related Experiment Video

Updated: Sep 17, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Lomotil ingestions in children

G S Wasserman, V A Green, G W Wise

    American Family Physician
    |June 1, 1975
    PubMed

    Insights

    Lomotil poses serious toxicity risks, especially in children, due to diphenoxylate hydrochloride and atropine. Respiratory depression is a critical adverse effect requiring naloxone treatment.

    Area of Science:

    • Pharmacology
    • Pediatric Toxicology

    Background:

    • Lomotil, a combination medication containing diphenoxylate hydrochloride and atropine, is used to treat diarrhea.
    • While generally safe in adults, its use in pediatric populations warrants careful consideration due to potential toxicity.

    Purpose of the Study:

    • To highlight the potential for serious adverse reactions to Lomotil in children.
    • To differentiate the early and late-onset toxic effects of Lomotil components.

    Main Methods:

    • Review of clinical data and pharmacological profiles of Lomotil's active ingredients.
    • Analysis of reported adverse events, focusing on pediatric cases.

    Main Results:

    • Adverse reactions to Lomotil are infrequent in adults but can be severe in children.
    • Early symptoms are often related to atropine, while later effects stem from diphenoxylate hydrochloride's opioid-like activity.
    • Respiratory depression is the most significant and life-threatening adverse event.

    Conclusions:

    • Lomotil administration requires heightened caution in pediatric patients due to the risk of serious toxicity.
    • Prompt recognition and management of respiratory depression with naloxone are crucial for favorable outcomes.

    More Related Videos

    Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children04:55

    Handheld Metal Detector Screening for Metallic Foreign Body Ingestion in Children

    Published on: September 11, 2018

    Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling07:11

    Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling

    Published on: February 5, 2019

    Related Concept Videos

    Prevention of Further Absorption of Poison01:14

    Prevention of Further Absorption of Poison

    In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
    Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

    Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

    Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
    Drugs Affecting GI Tract Motility: Other Laxatives01:20

    Drugs Affecting GI Tract Motility: Other Laxatives

    Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
    Osmotic or saline laxatives, like magnesium hydroxide or milk of...
    Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

    Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

    Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
    Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
    Drugs for Treatment of Constipation-Predominant IBS01:21

    Drugs for Treatment of Constipation-Predominant IBS

    Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...